Office of the Director, National Institutes of Health Notice of Meeting, 9072 [2022-03406]

Download as PDF 9072 Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices Dated: February 14, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. notwithstanding the inclusion of the routine notice. Elizabeth A. Fowler, Acting Deputy Director, Indian Health Service. [FR Doc. 2022–03406 Filed 2–16–22; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2022–03390 Filed 2–16–22; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Office of the Director, National Institutes of Health Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Science Advisory Board for Biosecurity. The meeting will be held as a virtual meeting and is open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov/). Name of Committee: National Science Advisory Board for Biosecurity. Date: February 28, 2022. Time: 12:00 p.m. to 1:00 p.m. Agenda: The National Science Advisory Board for Biosecurity meeting will include a review of the charge to the committee and discussion of next steps for the committee. Place: National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892 (Virtual Meeting Link is available at https://osp.od.nih.gov/biotechnology/ national-science-advisory-board-forbiosecurity-nsabb/#meetings). Contact Person: Cari Young, Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 301–496–9838, SciencePolicy@ od.nih.gov. Any interested person may file written comments by forwarding the statement to the Contact Person listed on this notice at least two days prior to the meeting date. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the NIH Office of Science Policy’s web page: https:// osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/, where an agenda, link to the webcast meeting, and any additional information for the meeting will be posted when available. This notice is being published less than 15 days prior to the meeting due to scheduling difficulties. VerDate Sep<11>2014 17:23 Feb 16, 2022 Jkt 256001 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR19–294: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK. Date: March 15, 2022. Time: 10:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Latha Meenalochana Malaiyandi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 812Q, Bethesda, MD 20892, (301) 435– 1999, malaiyandilm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Endocrinology, Metabolism, Nutrition and Reproductive Sciences. Date: March 15, 2022. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jonathan Michael Peterson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867–5309, jonathan.peterson@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR20–117: Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35— Clinical Trial Optional). PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Date: March 16–17, 2022. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Zubaida Rangwalla Saifudeen, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301.827.3029, zubaida.saifudeen@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Metabolism and Reproductive Sciences. Date: March 16, 2022. Time: 12:00 p.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Hui Chen, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, Bethesda, MD 20892, 301– 435–1044, chenhui@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; High Throughput Screening. Date: March 23, 2022. Time: 9:30 a.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sulagna Banerjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 612.309.2479, sulagna.banerjee@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 20–005: Transformative Research Award for the INCLUDE Project (R01). Date: March 24, 2022. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Katherine M. Malinda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301–435– 0912, katherine.malinda@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Topics: Biomaterials, Biointerfaces, Instrumentation, and Systems Development. Date: March 25, 2022. Time: 9:00 a.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Zarana Patel, Scientific Review Officer, The Center for Scientific E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 87, Number 33 (Thursday, February 17, 2022)]
[Notices]
[Page 9072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03406]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Science 
Advisory Board for Biosecurity.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below in 
advance of the meeting. The meeting will be videocast and can be 
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: February 28, 2022.
    Time: 12:00 p.m. to 1:00 p.m.
    Agenda: The National Science Advisory Board for Biosecurity 
meeting will include a review of the charge to the committee and 
discussion of next steps for the committee.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 750, Bethesda, MD 20892 (Virtual Meeting Link is available at 
https://osp.od.nih.gov/biotechnology/national-science-advisory-board-for-biosecurity-nsabb/#meetings).
    Contact Person: Cari Young, Office of Science Policy, National 
Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 
20892, 301-496-9838, [email protected].
    Any interested person may file written comments by forwarding 
the statement to the Contact Person listed on this notice at least 
two days prior to the meeting date. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the NIH Office of Science 
Policy's web page: https://osp.od.nih.gov/biotechnology/national-science-advisory-board-for-biosecurity-nsabb/, where an agenda, link 
to the webcast meeting, and any additional information for the 
meeting will be posted when available.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling difficulties.

    Dated: February 14, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03406 Filed 2-16-22; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.